Akebia Therapeutics
AKBA
#9606
Rank
โ‚ฌ97.57 M
Marketcap
0,35ย โ‚ฌ
Share price
-8.71%
Change (1 day)
-74.51%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): -0,14ย โ‚ฌ

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -0,15ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,01823ย โ‚ฌ an increase over its 2024 EPS that were of -0,30ย โ‚ฌ.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,14ย โ‚ฌ661.9%
2025-0,01823ย โ‚ฌ-93.94%
2024-0,30ย โ‚ฌ-16.83%
2023-0,36ย โ‚ฌ-23.7%
2022-0,47ย โ‚ฌ-69.41%
2021-1,55ย โ‚ฌ-38.63%
2020-2,53ย โ‚ฌ17.37%
2019-2,15ย โ‚ฌ2.79%
2018-2,09ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,79ย โ‚ฌ-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
15,84ย โ‚ฌ-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-6,11ย โ‚ฌ 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA